Posted on Sep 03, 2010

We have recently reported on the dangers of the weight loss drugs Alli and Xenical.  Doctors, researchers and now the FDA are all concerned about the possible liver injuries and even failures associated with the prescription drug.

Now another diet drug, Meridia, is being looked at for the dangers associated with its use.  In less than one month the FDA will be reviewing the safety of the prescription diet drug sibutramine, marketed as Meridia.  A study and editorial by the New England Journal of Medicine has revealed that the drug presents risks to many of those who take it. 

The study shows that sibutramine substantially increases the risk of non-fatal heart attacks and strokes in people with a history of cardiovascular disease who took the drug for an average of 3.4 years.  Earlier this year Europe decided to withdraw the drug from its market.

The Executive Editor of the New England Journal of Medicine Dr. George Curfman recently spoke about his concerns over the drug.

"It doesn't result in very much weight loss, and it doesn't improve their clinical condition.  On the other side, it carries these risks."


The Wisconsin class action attorneys at Hupy & Abraham are concerned about the seemingly constant barrage of warnings and drug recalls by the.  When a drug meant to heal does harm we all lose faith in both the FDA and big pharma.  If you believe that you have been injured by Meridia or any prescription drug please do not hesitate to contact an experienced attorney for a free consultation.

Read More About Diet Drug Meridia Found to Increase Heart Attack Risk...